News

This will contribute to the development of advanced therapies and diagnostic techniques for a wide variety of diseases. More information: Yoichi Otsuka et al, Single-cell mass spectrometry imaging ...
Researchers from Cybrexa Therapeutics Inc. presented new preclinical data on CBX-15, a peptide-drug conjugate (PDC) consisting of a pH-low insertion peptide (pHLIP) linked to monomethyl auristatin E ...
Through this collaboration and joint commercialization, this advancement enables users of Novoheart’s advanced hvCoC to analyze their data directly into Curi Bio’s Pulse analytics platform ...
using advanced bio-convergence technologies. The developed peptide therapy for dry age-related macular degeneration is one of the key materials identified through close cooperation with innovative ...
Cellino Biotech, which was founded in 2017, won a federal grant worth up to $25 million to continue to develop its advanced biomanufacturing technology. Dubbed NEBULA, the system aims to scale the ...
The new offering of bioresins from Advanced BioMatrix's provides Quantum X bio users with access to an expanded range of materials carefully developed for high-resolution 3D bioprinting.
with the team constantly updating the map based on their research, public data, and the industry's own input. The Trillium Network for Advanced Manufacturing’s Managing Director, Brendan Sweeney ...
Peptidream Inc. and Genentech Inc., a Roche Holding company, signed a deal worth up to $1 billion to discover and develop macrocyclic peptide-radioisotope (peptide-RI) drug conjugates. Peptidream, of ...
12, 2023 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ ... OPKO will supply its proprietary long-acting GLP-2 peptide and certain Oxyntomodulin (OXM) analogs for the development of oral tablet ...